National Academy of Agricultural Sciences (NAAS)
|
PRINT ISSN : 2319-7692
Online ISSN : 2319-7706 Issues : 12 per year Publisher : Excellent Publishers Email : editorijcmas@gmail.com / submit@ijcmas.com Editor-in-chief: Dr.M.Prakash Index Copernicus ICV 2018: 95.39 NAAS RATING 2020: 5.38 |
Forty sub-clinical endometritic (repeat breeding) cows were assigned to four groups, ten in each. Experimental design envisaged administration of Levamisole S/C, three injections at weekly interval @ 1ml/30kg body weight (group I), Restobal, a herbal drug 50 ml twice daily per animal orally for 10 days (group II), PHA-M @ 0.5 mg per cow through I/U once on the day of estrus (group III) and control (group IV) with no treatment. All the experimental cows were inseminated in the following estrus. Blood and uterine samples from each experimental animal were collected for evaluation of hematological parameters like haemoglobin concentration, total leucocyte count (TLC), differential count (DC) and uterine bacterial load during pre and post treatment period, consequent to various therapies as per standard procedures. The haemoglobin concentration (gm/dl), TLC values in different experimental groups did not reveal any significant difference at pre and post treatment period either within or between groups. In all the experimental groups the post treatment uterine bacterial count significantly receded (p<0.01) compared to their pre treatment values and also differed significantly (p<0.01) within and between the groups. The overall conception rate was highest (70 per cent) in group III subjected to therapy of PHA-M followed by 60%, 50% and 30% in Levamisole (group I), Restobal (group II) and control (group IV), respectively. Clinical management of sub-clinical endometritis (repeat breeding) by immunomodulating agents like PHA-M has got clinical importance.
Citations |
 |
 |
 |
 |
